M. Maass

F. Allerberger, M. Cormican, A. Rafila, 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Neutrophil Granulocytes and Delay Their Multiply in Chlamydia pneumoniae

Eresso Aga, W. Solbach, T. Laskay, 2004 .

Hydroxymethylglutaryl coenzyme A reductase inhibitors modify the inflammatory response of human macrophages and endothelial cells infected with Chlamydia pneumoniae.

H. Katus, J. Rupp, K. Dalhoff, 2000, Circulation.

pneumoniae Chlamydia Response of Human Macrophages and Endothelial Cells Infected With Hydroxymethylglutaryl Coenzyme A Reductase Inhibitors Modify the Inflammatory

H. Katus, J. Rupp, K. Dalhoff, 2000 .

Multicenter Comparison Trial of DNA Extraction Methods and PCR Assays for Detection of Chlamydia pneumoniae in Endarterectomy Specimens

G. Stanek, M. Kundi, C. Gaydos, 2001, Journal of Clinical Microbiology.

Critical Investigation of the CD14 Promoter Polymorphism: Lack of a Role for In Vitro Cytokine Response and Membrane CD14 Expression

J. Rupp, C. Hermann, S. von Aulock, 2005, Clinical Diagnostic Laboratory Immunology.

Critical Investigation of the CD 14 Promoter Polymorphism : Lack of a Role for In Vitro Cytokine Response and Membrane CD 14 Expression

J. Rupp, C. Hermann, S. Aulock, 2005 .

Chlamydia pneumoniae adversely modulates vascular cell properties by direct interaction with signalling cascades

M. Maass, J. Kern, V. Maass, 2009, Thrombosis and Haemostasis.

Molecular pathogenesis of chronic Chlamydia pneumoniae infection: a brief overview.

M. Maass, J. Kern, V. Maass, 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Chlamydophila pneumoniae induces expression of Toll-like Receptor 4 and release of TNF-α and MIP-2 via an NF-κB pathway in rat type II pneumocytes

M. Rüdiger, H. Wissel, E. Richter, 2005, Respiratory research.

Chlamydia pneumoniae pneumonia in hospitalized patients. Clinical characteristics and diagnostic value of polymerase chain reaction detection in BAL.

K. Dalhoff, M. Maass, 1996, Chest.

Interaction of Chlamydia pneumoniae and human alveolar macrophages: infection and inflammatory response.

K. Dalhoff, M. Maass, V. Redecke, 1998, American journal of respiratory cell and molecular biology.

Evaluation of culture conditions used for isolation of Chlamydia pneumoniae.

M. Maass, U. Harig, 1995, American journal of clinical pathology.

Antibacterial Resistance of Community- Acquired Respiratory Tract Pathogens Recovered from Patients in Germany and Activity of the Ketolide Telithromycin: Results from the PROTEKT Surveillance Study (1999–2000)

T. Wichelhaus, A. Rodloff, H. Seifert, 2004, Chemotherapy.

Presence of Chlamydia pneumoniae DNA in the cerebral spinal fluid is a common phenomenon in a variety of neurological diseases and not restricted to multiple sclerosis

F. Hanefeld, W. Solbach, J. Treib, 2001, Annals of neurology.

In Vitro Susceptibilities of Chlamydia pneumoniae Strains Recovered from Atherosclerotic Coronary Arteries

W. Solbach, J. Gieffers, M. Maass, 1998, Antimicrobial Agents and Chemotherapy.

Growth in serum-free medium improves isolation of Chlamydia pneumoniae

A. Essig, R. Marre, W. Henkel, 1993, Journal of clinical microbiology.

CD14 promoter polymorphism −159C>T is associated with susceptibility to chronic Chlamydia pneumoniae infection in peripheral blood monocytes

W. Solbach, J. Rupp, W. Goepel, 2004, Genes and Immunity.

Hydroxymethylglutaryl Coenzyme A Reductase Inhibition Reduces Chlamydia pneumoniae‐Induced Cell Interaction and Activation

R. Dietz, F. Luft, J. Rupp, 2003, Circulation.

Isolation of Chlamydia pneumoniae Clonal Variants by a Focus-Forming Assay

D. Crane, H. Caldwell, S. Ouellette, 2002, Infection and Immunity.

CNS infection with Chlamydia pneumoniae complicated by multiple strokes

H. Urbach, T. Klockgether, M. Minnerop, 2002, Journal of Neurology.

Phagocytes transmit Chlamydia pneumoniae from the lungs to the vasculature For editorial comments see page 499.

W. Solbach, J. Rupp, S. Ehlers, 2004, European Respiratory Journal.

Genotypic differences in the Chlamydia pneumoniae tyrP locus related to vascular tropism and pathogenicity.

H. Caldwell, J. Rupp, S. Ouellette, 2003, The Journal of infectious diseases.

Design and synthesis of 2-arylbenzimidazoles and evaluation of their inhibitory effect against Chlamydia pneumoniae.

J. Yli-Kauhaluoma, P. Vuorela, Leena Keurulainen, 2010, Journal of medicinal chemistry.

Alterations in the phenotype of CMV-specific and total CD8+ T-cell populations in Wegener's granulomatosis.

P. Klenerman, W. Solbach, P. Lamprecht, 2003, Cellular immunology.

Endarterectomy Specimens in Chlamydia pneumoniae Detection of Extraction Methods and PCR Assays for Multicenter Comparison Trial of DNA

G. Stanek, M. Kundi, C. Gaydos, 2001 .

Nod1-Mediated Endothelial Cell Activation by Chlamydophila pneumoniae

N. Suttorp, A. Hocke, S. Hippenstiel, 2005, Circulation research.

Infection of Human Umbilical Vein Endothelial Cells , Human Aortic Endothelial Cells , and HEK 293 Cells

N. Suttorp, A. Hocke, S. Hippenstiel, 2005 .

Expression Plasmids and HEK 293 Cell Overexpression Experiments

N. Suttorp, A. Hocke, B. Schmeck, 2005 .

Comparison of sample preparation methods for detection of Chlamydia pneumoniae in bronchoalveolar lavage fluid by PCR

K. Dalhoff, M. Maass, 1994, Journal of clinical microbiology.

Atherogenetically Relevant Cells Support Continuous Growth of Chlamydia Pneumoniae

W. Solbach, J. Gieffers, M. Maass, 2000, Herz.

In Vitro Susceptibility and Eradication of Chlamydia Pneumoniae Cardiovascular Strains from Coronary Artery Endothelium and Smooth Muscle Cells

W. Solbach, J. Gieffers, M. Maass, 2001, Cardiovascular Drugs and Therapy.

Inhibitory effect of the natural product betulin and its derivatives against the intracellular bacterium Chlamydia pneumoniae.

S. Alakurtti, J. Yli-Kauhaluoma, P. Vuorela, 2010, Biochemical pharmacology.

Serine-to-Asparagine Substitution in the GyrA Gene Leads to Quinolone Resistance in Moxifloxacin-Exposed Chlamydia pneumoniae

A. Gebert, W. Solbach, J. Rupp, 2005, Antimicrobial Agents and Chemotherapy.

Tropical rat mite dermatitis: case report and review.

U. Schramm, J. Welzel, H. Wolff, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada).

R. Peeling, S. Dowell, J. Guarner, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cluster of nosocomial campylobacteriosis, Austria 2006.

F. Allerberger, M. Hell, D. Schmid, 2008, The Journal of hospital infection.

Multiple sclerosis and Chlamydia pneumoniae

J. Treib, M. Grauer, R. Woessner, 2000, Annals of neurology.

Genetic diversity of the obligate intracellular bacterium Chlamydophila pneumoniae by genome-wide analysis of single nucleotide polymorphisms: evidence for highly clonal population structure

T. Rattei, W. Solbach, J. Rupp, 2007, BMC Genomics.

Detection of Taenia solium antigens in merthiolate-form preserved stool samples.

J. Knobloch, E. Delgado, M. Maass, 1991, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ).

Isolation of an immunodiagnostic Taenia solium coproantigen.

J. Knobloch, E. Delgado, M. Maass, 1992, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.

Sequence Homologies between Mycoplasma and Chlamydia spp. Lead to False-Positive Results in Chlamydial Cell Cultures Tested for Mycoplasma Contamination with a Commercial PCR Assay

M. Maass, J. Kern, V. Maass, 2011, Journal of Clinical Microbiology.

Recurrent optic neuritis associated with Chlamydia pneumoniae infection of the central nervous system.

F. Hanefeld, K. Rostásy, D. Pohl, 2006, Developmental Medicine & Child Neurology.

Mechanisms of target cell infection and activation

N. Suttorp, J. Rupp, M. Krüll, 2017 .

Chlamydophila pneumoniae

N. Suttorp, J. Rupp, M. Krüll, 2005, Thrombosis and Haemostasis.

Micromanipulation of the Chlamydia pneumoniae inclusion: implications for cloning and host-pathogen interactions.

H. Caldwell, R. Belland, J. Gieffers, 2003, FEMS microbiology letters.

Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis.

R. Dietz, C. Scheidereit, A. Leutz, 1999, Circulation.

Investigation of bacterial and viral agents and immune status in Behcet’s disease patients from Iran

D. Fuchs, F. Shahram, M. Herold, 2011, International journal of rheumatic diseases.

Detection of Chlamydia pneumoniae but not of Helicobacter pylori in symptomatic atherosclerotic carotids associated with enhanced serum antibodies, inflammation and apoptosis rate.

P. Heuschmann, T. Kirchner, M. Ocker, 2003, Atherosclerosis.

High-resolution melting analysis of the single nucleotide polymorphism hot-spot region in the rpoB gene as an indicator of reduced susceptibility to rifaximin in Clostridium difficile.

P. Hufnagl, F. Allerberger, A. Fiedler, 2012, Journal of medical microbiology.

Construction of a highly flexible and comprehensive gene collection representing the ORFeome of the human pathogen Chlamydia pneumoniae

D. Virok, J. Bauer, H. Hintner, 2012, BMC Genomics.

Pneumococcal septic shock is associated with the interleukin-10-1082 gene promoter polymorphism.

P. Zabel, K. Dalhoff, H. Esnaashari, 2003, American journal of respiratory and critical care medicine.

Mechanisms of Chlamydophila pneumoniae-mediated GM-CSF release in human bronchial epithelial cells.

J. Hegemann, N. Suttorp, F. N. Wuppermann, 2006, American journal of respiratory cell and molecular biology.

Chlamydia pneumoniae infection acts as an endothelial stressor with the potential to initiate the earliest heat shock protein 60-dependent inflammatory stage of atherosclerosis

A. Csordás, G. Almanzar, S. Kreutmayer, 2012, Cell Stress and Chaperones.

Proliferative stimulation of the vascular endothelin-1 axis in vitro and ex vivo by infection with Chlamydia pneumoniae

J. Rupp, M. Maass, J. Kern, 2009, Thrombosis and Haemostasis.

Differences in Cell Activation by Chlamydophila pneumoniae and Chlamydia trachomatis Infection in Human Endothelial Cells

N. Suttorp, A. Hocke, S. Hippenstiel, 2004, Infection and Immunity.

Association Between Infection With Helicobacter pylori and Chlamydia pneumoniae and Risk of Ischemic Stroke Subtypes: Results From a Population-Based Case-Control Study

P. Heuschmann, G. Faller, P. Kolominsky-Rabas, 2001, Stroke.

Clostridium difficile infection: monoclonal or polyclonal genesis?

S. Huhulescu, F. Allerberger, A. Indra, 2011, Infection.

Vasculitic purpura with antineutrophil cytoplasmic antibody-positive acute renal failure in a patient with Streptococcus bovis case and Neisseria subflava bacteremia and subacute endocarditis.

W. Jabs, B. Kreft, M. Maass, 2004, Clinical nephrology.

The endogenous antiseptic N‐chlorotaurine irreversibly inactivates Chlamydia pneumoniae and Chlamydia trachomatis

G. Weiss, M. Nagl, R. Bellmann-Weiler, 2018, Journal of medical microbiology.

Asymptomatic Carotid Atherosclerosis Is Associated With Circulating Chlamydia pneumoniae DNA in Younger Normotensive Subjects in a General Population Survey

U. John, C. Kessler, K. Berger, 2004, Arteriosclerosis, thrombosis, and vascular biology.

Time-Dependent Changes of hs-CRP Serum Concentration in Patients with Non-ST Elevation Acute Coronary Syndrome

H. Katus, E. Giannitsis, K. Dalhoff, 2004, Herz.

Failure To Detect Chlamydia pneumoniaein Brain Sections of Alzheimer's Disease Patients

W. Solbach, E. Reusche, J. Gieffers, 2000, Journal of Clinical Microbiology.

Chlamydia pneumoniae infection promotes a proliferative phenotype in the vasculature through Egr-1 activation in vitro and in vivo.

J. Rupp, U. Seitzer, E. Brandt, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Egr-1, a major link between infection and atherosclerosis?

J. Rupp, M. Maass, 2003, Circulation research.

Detection of Chlamydia pneumoniae in unexplained pulmonary hypertension

D. Theegarten, M. Maass, O. Anhenn, 2002, European Respiratory Journal.

Chlamydia pneumoniae directly interferes with HIF‐1α stabilization in human host cells

W. Solbach, J. Rupp, G. van Zandbergen, 2007, Cellular microbiology.

Chlamydia pneumoniae-induced pathological signaling in the vasculature.

M. Maass, J. Kern, V. Maass, 2009, FEMS immunology and medical microbiology.

Endothelial Chlamydia pneumoniae infection promotes oxidation of LDL.

M. Beckmann, J. Rupp, T. Maltaris, 2004, Biochemical and biophysical research communications.

Interaction of host and microbes in the atherosclerotic plaques

J. Rupp, M. Maass, 2004 .

Chlamydia pneumoniae in children with MS

F. Hanefeld, K. Rostásy, H. Reiber, 2003, Neurology.

Clinical aspects of 2009 pandemic influenza A (H1N1) virus infection in Austria

M. Hell, H. Burgmann, H. Herkner, 2011, Infection.

pneumoniae mediated GM-CSF expression 1 MECHANISMS OF CHLAMYDOPHILA PNEUMONIAE MEDIATED GM-CSF RELEASE IN HUMAN BRONCHIAL EPITHELIAL CELLS

N. Suttorp, F. N. Wuppermann, S. Hippenstiel, 2005 .

Cardiovascular infection by Chlamydia pneumoniae is not related to apolipoprotein E genotype.

W. Solbach, J. Gieffers, M. Maass, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Chlamydia pneumoniae infection acts as an endothelial stressor with the potential to initiate the earliest heat shock protein 60-dependent inflammatory stage of atherosclerosis

A. Csordás, G. Almanzar, S. Kreutmayer, 2013, Cell Stress and Chaperones.

Erratum to: “Transmission of Chlamydia pneumoniae infection from blood monocytes to vascular cells in a novel transendothelial migration model” [FEMS Microbiol. Lett. 242 (2005) 203–208]

W. Solbach, J. Rupp, M. Koch, 2005 .

Transmission of Chlamydia pneumoniae infection from blood monocytes to vascular cells in a novel transendothelial migration model.

W. Solbach, J. Rupp, M. Koch, 2005, FEMS microbiology letters.